Skip to main content
Tech.euFundingExplorerBeta
Funding rounds/Congenica

Congenica

Series B
Cambridge, UKApr 2017

Congenica closed a Series B round (amount undisclosed) in Apr 2017. The company is based in Cambridge, UK. Investors in the round: BGI Genomics (BGI), Future Planet Capital, Healthlink Capital (Healthlink). Data as of Nov 2026.

← Congenica
Amount raised
—
undisclosed
Native amount
—
Stage
Series B
series b
Investors
3

Provenance & confidence

Unverified
Amount

Amount undisclosed or unconverted.

Unverified
Source

finsmes.com · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Investors in this round

3 named
Date
Apr 2017
Round type
series b
Amount (EUR)
—

Related news